Journal Guide

Infectious Disease Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, rrinary tract infections, and viral infections.Infectious Disease Clinics of North America is published four times each year, March, June, September, and December.

Infectious Disease Modelling is a peer-reviewed open access journal aiming to promote research working to interface mathematical modelling, infection disease data retrieval and analysis, and public health decision support. The journal welcomes original research contributing to the enhancement of this interface, and review articles of cutting edge methodologies motivated by and applicable to data collection and informatics for public health decision making and policy.

L'organe d'expression de la Société de Pathologie Infectieuse de Langue Française (SPILF).Médecine et maladies infectieuses est indexée dans les principales bases de données internationales. Elle publie des articles scientifiques en anglais et en français, articles originaux, revues générales, communications brèves et lettres à la rédaction, qui abordent les différentes pathologies infectieuses et leurs agents pathogènes. Les axes d'étude de la revue concernent autant la clinique, la prévention, la biologie, les infections nosocomiales que l'épidémiologie et la thérapeutique.

Una publicación idónea para mantenerse al día sobre nuevos agentes patógenos, cepas resistentes... mediante los últimos trabajos de investigación clínicos y microbiológicos. Además es la Publicación Oficial de la SEIMC y posee un alto factor de impacto entre los profesionales.10 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/eimc

Infectious Diseases and Therapy is an open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on high quality pre-clinical, clinical (phases 1-4), and real world research around the discovery,  development, and use of infectious disease therapies. The journal also encourages diagnostic,  pharmacoeconomic, public health, educational, and quality of life studies as well as research around the prevention and management of infectious disease. Areas of focus include, but are not limited to, chronic infections, vaccines, drug-resistant pathogens, microbiology, epidemiology, and tropical, emergent, and sexually-transmitted diseases.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications. Each paper is accompanied by a bulleted slide summary to give a time-efficient overview of the content. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Infectious Diseases and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to clare.shepherd@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer., Your article will be immediately and permanently available with open access.

Medical professionals seeking an infectious diseases journal with true clinical value need look no further than Infectious Diseases in Clinical Practice. Here, clinicians can get full coverage consolidated into one resource, with pertinent new developments presented in a way that makes them easy to apply to patient care. Backed by the expertise and commitment of distinguished clinician-editors, the journal delivers the vital information needed to optimally prevent and treat infectious diseases.Website: www.infectdis.comIndividual and In-Training subscribers receive fully searchable online access to articles from Volume 1 to the present8212;now available on a powerful new website! This best-in-class website platform uses Web 2.0 functionality to provide an enhanced online experience through such features as: saved searches, personal article collections, easy image downloads to PowerPoint, and more.

Infectious Diseases in Obstetrics and Gynecology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to the management of infectious diseases in obstetrics and gynecology.

Infectious Diseases of Poverty is an open access, peer-reviewed journal publishing topic areas and methods that address essential public health questions relating to infectious diseases of poverty. These include various aspects of the biology of pathogens and vectors, diagnosis and detection, treatment and case management, epidemiology and modeling, zoonotic hosts and animal reservoirs, control strategies and implementation, new technologies and application. Transdisciplinary or multisectoral effects on health systems, ecohealth, environmental management, and innovative technology are also considered.

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Influenza and Other Respiratory Viruses is the first journal to specialise exclusively on influenza and other respiratory viruses and strives to play a key role in the dissemination of information in this broad and challenging field. It is aimed at laboratory and clinical scientists, public health professionals, and others around the world involved in a broad range of activities in this field. In turn, topics covered will include: surveillance epidemiology prevention by vaccines prevention and treatment by antivirals clinical studies public health & pandemic preparedness basic scientific research transmission between animals and humans Aims and Scope Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Effective with the 2013 Volume, Influenza and other Respiratory Viruses will be published in an Online Only format. No printed issue will be produced but authors will still be able to order offprints of their own articles. In 2014, Influenza and Other Respiratory Viruses will be joining the Wiley Open Access publishing program of fully open access journals published by Wiley. For further information visit the Wiley Open Access website. From January 2014, all articles published by Influenza and Other Respiratory Viruses will be fully open access: immediately freely available to read, download and share. All accepted articles submitted from 1st October 2013 are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.

Innate Immunity is a highly ranked, peer reviewed scholarly journal, first published as Journal of Endotoxin Research (JER) in 1994 as the official journal of the International Endotoxin Society (IES). Over 10 years of being known as the IES, the society recognised a significant increase in research in innate immunity not related to endotoxins. In response to this the society became the International Endotoxin and Innate Immunity Society (IEIIS) in 2005.The journal’s coverage has changed in line with the society, and it increasingly publishes articles dealing with innate immunity research not related to endotoxins. A joint decision was made between the publisher and the IEIIS to re-launch the journal in 2008 with the new name Innate Immunity, to reflect the broader range of coverage of the society and in the journal.Publication Charge from July 2010:Innate Immunity has seen a large increase in the number of submitted manuscripts in recent years. In order to publish this important research in a timely manner we will be increasing by 33% the number of pages in each volume. After consultation with the Editorial Board and recent authors, we will cover the increased cost of production by introducing a charge of $230 for all accepted papers. The subscription price will remain at its current level in 2010.IEIIS President Alan Cross adds, "The International Endotoxin and Innate Immunity Society supports the move to introduce publication fees for Innate Immunity. This change will enable the journal to publish more high quality articles every year, and reduce the publication times for important new research"In rare cases of genuine financial hardship, exemptions may be made at the discretion of the publisher. Please contact dan.huke@sagepub.co.uk for further information.

Interdisciplinary Perspectives on Infectious Diseases is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of infectious diseases.

The International Journal for Parasitology publishes the results of original research in all aspects of basic and applied parasitology, including all the fields covered by its Specialist Editors, and ranging from parasites and host-parasite relationships of intrinsic biological interest to those of social and economic importance in human and veterinary medicine and agriculture. Original research includes the development of novel and innovative concepts and ideas, as well as experimental and observational science that raises new hypotheses. Because of its breadth of discipline coverage, the aims and significance of all contributions should be made clear to readers who are not expert in the particular subject of papers. In applied parasitology, it will tend to favour contributions of broader significance to the subject rather than narrow, highly specialised applications. The principal form of publication is the full length paper which contains substantial results from a major program of research. The Journal also provides a medium for the publication of shorter, but complete, papers reporting highly significant original findings, as Succinctus articles. It also publishes Thematic Issues incorporating papers on a topical theme and commissions papers with emphasis on shorter, focussed Reviews of topical issues and strategically important subjects. The Journal encourages critical comment and debate on matters of current controversy in parasitology via "Current Opinions".Most downloaded papersBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The International Journal for Parasitology – Drugs and Drug Resistance publishes the results of original research in the area of anti-parasite drug identification, development and evaluation, and parasite drug resistance. The journal also covers research into natural products as anti-parasitic agents, and bioactive parasite products. Studies can be aimed at unicellular or multicellular parasites of human or veterinary importance.A list showing the types of articles that are considered is included below. Original research includes the development of novel and innovative concepts and ideas, as well as experimental and observational science that raises new hypotheses. Because of its breadth of organism coverage, all contributions should include relevant information about the parasite of interest in order to be comprehensible to non-experts in the particular subject of the articles. The principal form of publication is the full length article which contains substantial results from a major program of research. The journal also accepts brief reports that have similar subject scope as the full-length article, but do not merit a full-length publication.In addition, the journal provides a medium for highlighting selected articles reporting highly significant original findings, as Editor's Choice Manuscripts. It also commissions articles with emphasis on shorter, focused Reviews of topical issues and strategically important subjects. The journal encourages critical comment and debate on matters of current controversy in the area of parasite drug resistance and anti-parasite drugs via "Current Opinions".This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).Types of articles considered:Compound library screening for inhibitors against enzymes or whole parasitesDrug target validation (chemical and/or genetic)Drug target identification (must include some inhibitor studies rather than characterisation of an enzyme, for example)Drug structure-activity relationship studiesMechanisms of drug action and resistanceReports of the development of drug resistance both in the field and laboratoryStudies on drug toxicity to the host (either on single host cells or whole organism)Reports on toxicity in the fieldComputational approaches to drug discovery or drug-target identificationDevelopment of assays directed at screening for inhibitorsDrug combination studiesNatural products as anti-parasitic agentsBioactive products produced by parasitesUse of live parasites as immunomodulatory agentsEpidemiological aspects of the emergence and spread of parasite drug resistanceHuman clinical trials

The International Journal for Parasitology: Parasites and Wildlife (IJP-PAW) publishes the results of original research on parasites of all wildlife, invertebrate and vertebrate. This includes free-ranging, wild populations, as well as captive wildlife, semi-domesticated species (e.g. reindeer) and farmed populations of recently domesticated or wild-captured species (e.g. cultured fishes). Articles on all aspects of wildlife parasitology are welcomed including taxonomy, biodiversity and distribution, ecology and epidemiology, population biology and host-parasite relationships. The impact of parasites on the health and conservation of wildlife is seen as an important area covered by the journal especially the potential role of environmental factors, for example climate. Also important to the journal is 'one health' and the nature of interactions between wildlife, people and domestic animals, including disease emergence and zoonoses.The principal form of publication is the full-length article which contains substantial, original research. The journal also accepts brief reports that have similar subject scope as the full-length article, but do not merit a full-length publication. In addition, the journal commissions articles with emphasis on shorter, focused reviews of topical and emerging issues as well as strategically important subjects. The journal encourages critical comment and debate on matters of current controversy in the area of parasites and wildlife via "Current Opinions".This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).

The International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.Additional information on the ISC and its activities can be found at the ISC Web site at:http://www.ischemo.orgBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The International Journal of Hygiene and Environmental Health serves as a multidisciplinary forum for original reports on exposure assessment and the reactions to and consequences of human exposure to the biological, chemical, and physical environment. Research reports, short communications, reviews, scientific comments, technical notes, and editorials will be peer-reviewed before acceptance for publication. High priority will be given to articles on epidemiological aspects of environmental toxicology, health risk assessments, susceptible (sub) populations, human biomonitoring, environment and health-related infections, occupational and environmental medicine, and public health aspects of exposure-related outcomes.